| 1 |
33903887 | [Dexmedetomidine alleviates hepatic ischemia-reperfusion injury by regulating MALAT1/miR-126-5p/HMGB1 axis]. | 2021 Apr 25 |
2 |
| 2 |
34101714 | Neuroprotective effects of intraoperative dexmedetomidine versus saline infusion combined with goal-directed haemodynamic therapy for patients undergoing cranial surgery: A randomised controlled trial. | 2021 Dec 1 |
1 |
| 3 |
34237593 | Dexmedetomidine preconditioning mitigates myocardial ischemia/reperfusion injury via inhibition of mast cell degranulation. | 2021 Sep |
3 |
| 4 |
30675709 | Dexmedetomidine Preconditioning Protects Cardiomyocytes Against Hypoxia/Reoxygenation-Induced Necroptosis by Inhibiting HMGB1-Mediated Inflammation. | 2019 Feb |
5 |
| 5 |
30958608 | Dexmedetomidine protects against high mobility group box 1-induced cellular injury by inhibiting pyroptosis. | 2019 Jun |
4 |
| 6 |
29241031 | The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways. | 2018 Feb |
4 |
| 7 |
29853785 | Effects of Dexmedetomidine Infusion on Inflammatory Responses and Injury of Lung Tidal Volume Changes during One-Lung Ventilation in Thoracoscopic Surgery: A Randomized Controlled Trial. | 2018 |
1 |
| 8 |
22939552 | Dexmedetomidine inhibits the secretion of high mobility group box 1 from lipopolysaccharide-activated macrophages in vitro. | 2013 May |
6 |